U.S. commits $1.2 billion to production of Oxford vaccine
President Trump has launched Operation Warp Speed, which aims to make millions of doses of a coronavirus vaccine available by years end.
Vaccine
Monkeys show immunity after COVID infection
A possible COVID-19 vaccine is still months away, but now there is new hope that antibodies could provide immunity against the disease. Dr. Neeta Ogden joined CBSN to discuss two new studies that looked at how monkeys with coronavirus reacted to being re-infected and what that could mean for human immunity.
Monkey trials show promising COVID-19 vaccine results
Researchers in Boston revealed stunning news on Wednesday: After they immunized 25 rhesus monkeys with DNA vaccines, the monkeys didn't get sick.
Issues may impact COVID-19 vaccine
Moderna Therapeutics is touting results from its first phase of testing for a coronavirus vaccine. But problems are likely to arise once a cure is developed. Politico's health care reporter Sarah Owermohle joins CBSN's Reena Ninan to explain how the Trump administration may have issues with distributing and developing a vaccine.
Unvaccinated kids banned from N.Y. schools
Anti-vaccine activists descended on Albany, New York on Friday to protest a new state law barring unvaccinated children from schools. Unvaccinated students had been allowed to attend school for 14 days before they would be barred -- and that grace period ended for many students last week.
Get flu shot by end of October, officials say
The Centers for Disease Control and Prevention is urging everyone 6 months and older to get vaccinated as the new flu season gets underway. CBS News' Mark Liverman reports.
A new deadly virus could decimate the rabbit population
Rabbits are currently battling a viral disease of their own, and it could wipe out entire populations.
Could COVID-19 vaccine be ready by year's end? Moderna is hopeful
The company is expected to begin the second phase of the drug trial soon.
Moderna outlines vaccine progress
President of biotech firm Moderna Stephen Hoge tells CBS News about the company's progress in the trials for its COVID-19 vaccine. The first eight participants developed some antibodies after a single dose. The company hopes to distribute its vaccine by early next year.
Promising coronavirus vaccine trial
The biotech firm Moderna Therapeutics announced that the first eight participants in the Phase 1 of its COVID-19 vaccine trial developed some antibodies after a single dose. Moderna is now expected to start a second round of clinical trials as soon as next month. Dr. David Agus joined "CBS This Morning" to explain the development and the latest in the race for a vaccine.
The race to treat or prevent COVID-19
The rapid spread of the COVID-19 virus has prompted medical researchers worldwide to go on the offense and look for vaccines and treatments. Bill Whitaker reports on some of the leading efforts.
China says it will back probe into virus origin, but not yet
Beijing says it "took an active part" in drafting a formal call at the World Health Organization for a global investigation into the source of the coronavirus.
Trump praises his admin.'s handling of pandemic
President Trump spent the weekend at Camp David, where he tweeted out praise for the "great job" his administration had done responding to the coronavirus pandemic. Meanwhile, health experts warn a vaccine may still be far off and Congress can't come to terms on additional stimulus measures. Nikole Killion reports.
Fed chair on when the economy could recover
"This economy will recover. It may take a while," Federal Reserve Chairman Jerome Powell told Scott Pelley in an interview airing on "60 Minutes."
Azar aiming for 300 million vaccine doses by year's end
The health and human services secretary says the administration is pursuing multiple vaccines with the goal of 300 million doses by 2021.
Transcript: Alex Azar on "Face the Nation"
The following is a transcript of an interview with Health and Human Services Secretary Alex Azar that aired Sunday, May 17, 2020, on "Face the Nation."
Potential COVID-19 treatment enters new testing phase
The National Institutes of Health say researchers have begun testing a potential coronavirus vaccine. Meanwhile, another blend of drugs designed to fight COVID-19 has entered a new phase. Dr. Jon LaPook has the latest in CBS News' "Racing to a Cure" series.
House passes $3 trillion coronavirus aid bill
The House of Representatives voted to pass the largest relief package in U.S. history on Friday evening, but the $3 trillion bill faces an uphill battle in the Senate and White House. Meanwhile, President Trump is at Camp David with several Republican lawmakers this weekend after setting an ambitious target to develop a coronavirus vaccine by the end of the year. Nikole Killion breaks down what's inside the historic relief package.
Trump: "Vaccine or no vaccine, we're back"
President Trump says "vaccine or no vaccine", the country will move forward with plans to reopen. More than two thirds of the states have now relaxed restrictions. Paula Reid reports.
Monkey trial of Oxford vaccine shows encouraging results
When they exposed the animals to coronavirus, the monkeys that weren't vaccinated developed pneumonia, a sign of COVID-19 — but those that weren't vaccinated did not.
Vaccine law on the ballot in Maine
WGME reports Maine voters will decide in a referendum in March whether to uphold stronger vaccine requirements for children. CBS affiliate WGME-TV reports.
Trump announces top officials for coronavirus vaccine effort
Moncef Slaoui and General Gustave Perna will lead the federal government's effort to develop and distribute a vaccine as quickly as possible.
Trump on vaccine development
President Trump on Friday announced Dr. Moncef Slaoui and Gen. Gustave Perna will lead the federal government's effort to develop and distribute a coronavirus vaccine as quickly as possible. Watch his remarks.
Coronavirus could lead to drug shortages in U.S.
The coronavirus is threatening the U.S. medical supply chain as it shuts down factories in China, where many of the core components of drugs sold in the U.S. are made.
Fact vs. fiction about coronavirus
As the coronavirus spreads worldwide, there is a lot of misinformation surrounding the outbreak. Dr. Max Gomez offers his insights to CBSN New York.
Trump waives tariffs on largest buyers of Russian oil
Oregon school shooter ID'd, used shotgun bought by mother, sources say
Exclusive
Sacramento mom says hero son shot, killed Oregon school shooter
On economy, Vance says "we're turning the ship around"
Pope Leo discharged from hospital on Saturday, four days after surgery
Live
Reported attacks on ships around Strait of Hormuz reach record highs
Katie Zacharia out as White House press secretary after first week
Sean "Diddy" Combs moved to prison in Pennsylvania
